Differential strain-related tissue immune response to sublethal systemic Aspergillus fumigatus infection in mice

APMIS

Volumn 121, Issue 3, 2013, Pages 211-220

  Mirkov, Ivana ^a   Glamoclija, Jasmina ^a   Stosic Grujicic, Stanislava ^a   Zolotarevski, Lidija ^b   Kataranovski, Dragan ^a   Kataranovski, Milena ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF DEFENCE   (Serbia)

Author keywords

Aspergillus fumigatus; BALB c and C57BL 6 mice; Systemic infection; Tissue immune response

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPERGILLOSIS; CONIDIUM; CONTROLLED STUDY; FEMALE; FUNGAL STRAIN; IMMUNE RESPONSE; KIDNEY; LIVER; LUNG ALVEOLUS CELL; MACROPHAGE; MOUSE; NEUTROPHIL COUNT; NONHUMAN; PRIORITY JOURNAL; TISSUE INJURY; UPREGULATION;

ANIMALS; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CYTOKINES; FEMALE; INTERFERON-GAMMA; INTERLEUKIN-1BETA; INTERLEUKIN-4; INTERLEUKIN-6; KIDNEY; LIVER; LUNG; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NEUTROPHILS; PULMONARY ASPERGILLOSIS; TH1 CELLS; TH2 CELLS; UP-REGULATION;

EID: 84874193833     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2012.02958.x     Document Type: Article

References (30)

1. Segal BH, Walsh TJ. Current approaches to diagnosis and treatment of invasive aspergillosis. Am J Respir Crit Care Med 2006;173:707-17.
2. Segal BH. Aspergillosis. N Engl J Med 2009;360:1870-84.
3. Clemons KV, Stevens DA. The contribution of animal models of aspergillosis to understanding pathogenesis, therapy and virulence. Med Mycol 2005;43:S101-10.
4. Sheppard DC, Graybill JR, Najvar LK, Chiang LY, Doedt T, Kirkpatrick WR, et al. Standardization of an experimental murine model of invasive pulmonary aspergillosis. Antimicrob Agents Chemother 2006;50:3501-3.
5. Cenci E, Perito S, Enssle KH, Mosci P, Latge JP, Romani L, et al. Th1 and Th2 cytokines in mice with invasive aspergillosis. Infect Immun 1997;65:564-70.
6. Clemons KV, Grunig G, Sobel RA, Mirels LF, Rennick DM, Stevens DA. Role of IL-10 in invasive aspergillosis: increased resistance of IL-10 gene knockout mice to lethal systemic aspergillosis. Clin Exp Immunol 2000;122:186-91.
7. Clemons KV, Martinez M, Tong AJ, Stevens DA. Resistance of MBL gene-knockout mice to experimental systemic aspergillosis. Immunol Lett 2010;128:105-7.
8. Mirkov I, Stosic-Grujicic S, Kataranovski M. Host immune defense against Aspergillus fumigatus: insight from experimental systemic (disseminated) infection. Immunol Res 2012;52:120-6.
9. Mirkov I, Zolotarevski L, Glamocija J, Kataranovski D, Kataranovski M. Experimental disseminated aspergillosis in mice: histopatho-logical study. J Mycol Med 2008;18:75-82.
10. Safdar A. Immunomodulation therapy for invasive aspergillosis: discussion on myeloid growth factors, recombinant cytokines and antifungal drug immune modulation. Curr Fungal Infect Rep 2010;4:1-7.
11. Mirkov I, Stojanovic I, Stosic-Grujicic S, Glamoclija J, Zolotarevski L, Kataranovski D, et al. Splenic and lung response to nonlethal systemic Aspergillus fumigatus infection in C57BL/6 mice. Med Mycol 2010;48:735-43.
12. Stojanovic I, Mirkov I, Kataranovski M, Glamoclija J, Stosic-Grujicic S. A role for macrophage migration inhibitory factor in protective immunity against Aspergillus fumigatus. Immunobiology 2011;216:1018-27.
13. Mirkov I, Stojanovic I, Glamoclija J, Stosic-Grujucic S, Zolotarevski L, Kataranovski D, et al. Differential mechanisms of resistance to sublethal systemic Aspergillus fumigatus infection in immunocompetent BALB/c and C57BL/6 mice. Immunobiology 2011;216:234-42.
14. Mirkov I, Belij S, Kataranovski M, Zolotarevski L, Stojanovic I, Stosic-Grujicic S. The relevance of the migration inhibitory factor (MIF) for peripheral tissue response in murine sublethal systemic Aspergillus fumigatus infection. Med Mycol 2012;250:476-87.
15. Booth C. Fungal Culture Media. In: Norris JR, Ribbons DW, editors. Methods in Microbiology. London & New York: Academic Press, 1971: 49-94.
16. Choi HS, Kim JW, Cha YN, Kim C. A quantitative nitroblue tetrazolium assay for determining intracellular superoxide anion production in phagocytic cells. J Immunoassay Immunochem 2006;27:31-44.
17. Bonnett CR, Cornish EJ, Harmsen AG, Burritt JB. Early neutrophil recruitment and aggregation in the murine lung inhibit germination of Aspergillus fumigatus conidia. Infect Immun 2006;74:6528-39.
18. Cenci E, Mencacci AFe d'Ostiani C, Del Sero G, Mosci P, Montagnoli C, et al. Cytokine- and T helper- dependent lung mucosal immunity in mice with invasive pulmonary aspergillosis. J Infect Dis 1998;178:1750-60.
19. Kuebler WM. Inflammatory pathways and microvascular responses in the lung. Pharmacol Rep 2005;57(Suppl):196-205.
20. Philippe B, Ibrahim-Granet O, Prevost MC, Gougerot-Pocidalo MA, Sanchez Perez M, Van der Meeren A, et al. Killing of Aspergillus fumigatus by alveolar macrophages is mediated by reactive oxidant intermediates. Infect Immun 2003;71:3034-42.
21. Mills CD, Kincaid K, Alt JM, Heilman MJ, Hill AM. M-1/M-2 macrophages and the Th1/Th2 paradigm. J Immunol 2000;164:6166-73.
22. Bhatia S, Fei M, Yarlagadda M, Qi Z, Akira S, Saijo S, et al. Rapid host defense against Aspergillus fumigatus involves alveolar macrophages with a predominance of alternatively activated phenotype. PLoS ONE 2011;6:e15943.
23. Brieland JK, Jackson C, Menzel F, Loebenberg D, Cacciapuoti A, Halpern J, et al. Cytokine networking in lungs of immunocompetent mice in response to inhaled Aspergillus fumigatus. Infect Immun 2001;69:1554-60.
24. Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989;7:145-73.
25. Roilides E, Uhlig K, Venzon D, Pizzo PA, Walsh TJ. Enhancement of oxidative response and damage caused by human neutrophils to Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon. Infect Immun 1993;61:1185-93.
26. Zelante T, De Luca A, Bonifazi P, Montagnoli C, Bozza S, Moretti S, et al. IL-23 and Th17 pathway promote inflammation and impair antifungal immune resistance. Eur J Immunol 2007;37:2695-706.
27. Zelante T, Bozza S, De Luca A, D'Angelo C, Bonifazi P, Moretti S, et al. Th17 cells in the setting of Aspergillus infection and pathology. Med Mycol 2009;47:S162-9.
28. Thach DC, Kimura T, Griffin DE. Differences between C57BL/6 and BALB/cBy mice in mortality and virus replication after intranasal infection with neuroadapted Sindbis virus. J Virol 2000;74:6156-61.
29. Wakeham J, Wang J, Xing Z. Genetically determined disparate innate and adaptive cell-mediated immune responses to pulmonary Myco-bacterium bovis BCG infection in C57BL/6 and BALB/c mice. Infect Immun 2000;68:6946-53.
30. Naik SR, Thakare VN, Desai SK, Rahalkar PR. Study of immunological aspects of aspergillosis in mice and effect of polyene macrolide antibiotic (SJA-95) and IFN-γ: a possible role of IFN-γ as an adjunct in antifungal therapy. Immunol Lett 2011;141:68-73.